Your browser doesn't support javascript.
Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy.
Liu, Hui; Li, Ping; Zhao, Aiqi; Lei, Wen; Liang, Aibin; Qian, Wenbin.
  • Liu H; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Li P; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, People's Republic of China.
  • Zhao A; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Lei W; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Liang A; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, People's Republic of China.
  • Qian W; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Leuk Lymphoma ; 63(4): 1001-1004, 2022 04.
Article in English | MEDLINE | ID: covidwho-1972858
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, B-Cell / Receptors, Chimeric Antigen / Herpes Zoster Type of study: Observational study Limits: Humans Language: English Journal: Leuk Lymphoma Journal subject: Hematology / Neoplasms Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, B-Cell / Receptors, Chimeric Antigen / Herpes Zoster Type of study: Observational study Limits: Humans Language: English Journal: Leuk Lymphoma Journal subject: Hematology / Neoplasms Year: 2022 Document Type: Article